Answers are grounded in this paper and cite their sources.
Insulin plays a vital role in brain physiology, and brain insulin resistance (BIR) is increasingly recognised as a key contributor to Alzheimer’s disease (AD) pathology. Emerging evidence links BIR to type 2 diabetes (T2D) and obesity, where it is associated with cognitive decline, impaired peripheral metabolic regulation, and altered brain glucose metabolism. BIR may further exacerbate adverse peripheral metabolic conditions, highlighting its role as a potential driver of disease progression. Targeting BIR could be important in preventing or delaying the onset of AD in individuals with T2D, as argued in this review.
No takes yet. Share an insight, caveat, or question.
Porse et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: